Bortezomib-loaded mixed micelles realize a “three-in-one” effect for enhanced breast cancer treatment-Reference-Cited by-同舟云学术

Bortezomib-loaded mixed micelles realize a “three-in-one” effect for enhanced breast cancer treatment

Published:2023 Issue:14 Volume:11 Page:4890-4906
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Liu Jianhao¹^ORCID,Xu Xiaoman¹^ORCID,Li Yanying²,Xu Jingxia¹^ORCID,Zhao Ruogang¹^ORCID,Liu Siwei²^ORCID,Wu Jingliang²^ORCID,Zhang Li¹³,Zhang Bo¹^ORCID

Affiliation:

1. School of Pharmacy, Weifang Medical University, Weifang 261053, P.R. China

2. School of Bioscience and Technology, Weifang Medical University, Weifang, Shandong, 261053, P.R. China

3. College of Traditional Chinese Medicine, Weifang Medical University, Weifang 261053, Shandong, P.R. China

Abstract

BTZ-LGs can achieve a “three-dimensional synergistic” effect in terms of killing tumor cells, suppressing CAFs, and improving immune responses.

Funder

Natural Science Foundation of Shandong Province

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/BM/D3BM00254C

Reference56 articles.

1. COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer

2. Breast cancer: presentation, investigation and management

3. Current and future burden of breast cancer: Global statistics for 2020 and 2040

4. Tumor microenvironment as a therapeutic target in cancer

5. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoscale strides: exploring innovative therapies for breast cancer treatment;RSC Advances;2024